Statistical Service of Cyprus

Health Unit - Demography, Social Statistics and Tourism Department

Michael Karaolis Str. 

Health care expenditure quantifies the economic resources dedicated to health functions, excluding capital investment. Healthcare expenditure concerns itself primarily with healthcare goods and services that are consumed by resident units, irrespective of where that consumption takes place (it may be in the rest of the world) or who is paying for it. As such, exports of healthcare goods and services (to non-resident units) are excluded, whereas imports of healthcare goods and services for final use are included.
Health care expenditure data provide information on expenditure in the functionally defined area of health distinct by provider category (e.g. hospitals, general practitioners), function category (e.g. services of curative care, rehabilitative care, clinical laboratory, patient transport, prescribed medicines) and financing scheme (e.g. social security, private insurance company, household). For the collection of the data on health care expenditure the System of Health Accounts (SHA) and its related set of International Classification for the Health Accounts (ICHA) is used. SHA sets out an integrated system of comprehensive and internationally comparable accounts and provides a uniform framework of basic accounting rules and a set of standard tables for reporting health expenditure data. The System of Health Accounts - SHA 2011 is a statistical reference manual giving a comprehensive description of the financial flows in health care.

It provides a set of revised classifications of health care functions, providers of health care goods and services and financing schemes. The SHA is currently used as a basis for a joint data collection by OECD, Eurostat and WHO on health care expenditure. The manual sets out in more detail the boundaries, the definitions and the concepts of health accounting – responding to health care systems around the globe with very different organisational and financing arrangements.

Accounting period: Health expenditure and financing data pertain to the calendar year (1 January to 31 December).
The time coverage of this Quality report is 2010 to 2017 reference years.

Healthcare expenditure is recorded in relation to the international classification for health accounts (ICHA) defining:

• healthcare expenditure by financing schemes (ICHA-HF) — which classifies the types of financing arrangements through which people obtain health services; health care financing schemes include direct payments by households for services and goods and third-party financing arrangements;
• healthcare expenditure by function (ICHA-HC) — which details the split in healthcare expenditure following the purpose of healthcare activities — such as, curative care, rehabilitative care, long-term care, or preventive care;
• healthcare expenditure by provider (ICHA-HP) — which classifies units contributing to the provision of healthcare goods and services — such as hospitals, residential facilities, ambulatory health care services, ancillary services or retailers of medical goods.

1. Household individual consumption on health, including the collective consumption with two exceptions:
i. Occupational health care (intermediate consumption within establishments) minus an estimated share of occupational health in health providers’ and other medical industries net administration;
ii.“Remunerated” unpaid household production in the form of transfer payments (social benefits in cash) for home care of sick, disabled and elderly persons provided by family members.
SHA 2011 Manual recommends following the standard System of National Account (SNA) rules for drawing the production boundary of health care services, albeit with two notable exceptions:
- Occupational health care is included in the national totals of health care spending. In SNA, this item is recorded as ancillary services and part of intermediate production of enterprises and
- Part of the cash transfers to private households for care givers of home care for the sick and disabled are treated as the paid household production of health care.
2. Health care financing schemes: HF1 Government schemes and compulsory contributory health care financing schemes; HF2 -voluntary health care payment schemes;
HF3 - Household out-of-pocket payment; HF4 - rest of the world financing schemes.
3. NACE rev. 2, section Q, human health and social work activities.

SHA concept is the consumption of health care goods and services.
Health care statistics describe the process of providing and financing health care in countries by referring to health care goods and services, its providers and financing. For the collection of the data on health care expenditure the System of Health Accounts (SHA) and its related set of International Classification for the Health Accounts (ICHA) is used. SHA is a tri-axial system in which the financing, provision and consumption dimensions are covered by the ICHA (International Classification for Health Accounts): Health Care Functions (HC), Health Care Providers (HP), Health Care Financing Schemes (HF).
Data are presented in 3 summary (one-dimensional) tables and 3 cross-classification tables (2-dimensional tables).

Summary tables provide data on:

• Current expenditure by provider (ICHA-HP)
• Current expenditure by function (ICHA-HC)
• Current expenditure by financing scheme (ICHA-HF)

Cross-classification tables refer to:

• HC x HP: Health care expenditure by function and provider: data on which type of health care goods and services are supplied by which health care provider;
• HC x HF: Health care expenditure by function and by financing scheme: data on how are the different types of services and goods financed;
• HP x HF: Health care expenditure by provider and by financing scheme: data on from which health care provider and under which particular financing scheme are the services and goods purchased.

Commission Regulation 2015/359 concerns the collection of data on "current expenditure on healthcare" which is defined as the "final consumption expenditure of resident units on health care goods and services".
There is a very close relationship between the concept of "final consumption expenditure" as defined in the System of Health Accounts (SHA) and in National Account and, as a consequence, also between the underlying economic transactions as recorded in the two accounting frameworks.
In National Accounts there are two types of statistical units: institutional units and local kind-of-activity units (KAU). A local KAU groups all the parts of an institutional unit in its capacity as producer which are located in a single site. A local KAU belongs to one and only one institutional unit.
SHA uses the same two types of units for data compilation.
Local KAUs operating as providers of healthcare goods and services to resident units are statistical units in SHA.
Also transactions by institutional units are recorded in SHA, in which framework institutional units are also referred to as "financing agents". More precisely, SHA financing agents are institutional units that manage one or more financing schemes. The transactions are executed by the financing agents, according to the rules of the financing schemes.
Financing agents serve as key statistical units in producing national health accounts. While financing schemes are the key units for analysing how the consumption of health care goods and services is financed, the data concerning the relevant transactions are collected either from the financing agents that operate the different financing schemes or from the providers.
The concept of "healthcare financing schemes" in SHA is an application and extension of the concept of "social protection schemes" defined by the European System of Social PROtection Statistics (ESSPROS):  "a distinct body of rules, supported by one or more institutional units, governing the provision of social protection benefits and their financing ...". The social protection scheme is the statistical unit in ESSPROS. It is an analytical unit that allows describing the complete structure of the social protection financing system:  expenditure and receipts.
According to SHA Manual 2011, "the key concepts for describing the structure of the health care financing system are based on measuring: (a) the expenditure of health care financing schemes, under which goods and services are purchased directly from health care providers, on the one hand, and (b) the types of revenues of health care financing schemes, on the other hand.  
Commission Regulation 2015/359 limits its scope to the collection of data on the expenditure of health care financing schemes.

SHA focuses on the consumption of health care goods and services by the resident population irrespective of where this takes place. This implies the inclusion of imports (from non-resident providers) and the exclusion of exports (health care goods and services provided to non-residents).

The data aims at providing a complete overview of expenditure on health care goods and services consumption of services and goods by the resident population on the national territory of a country.

Detailed data according to SHA2011 is available for the period 2010-2017 for Cyprus.

Not applicable.

Several data sources are used (as of data notification in March 2019):

-          Surveys/census: 3

-          Public administrative records: 5

-          Financial reports: 3

-          Other: 0

Surveys/censuses

Public administrative records

Financial reports

Annual.

Data are collected through the joint health accounts questionnaire (JHAQ) that countries submit to Eurostat during the annual data collection exercise. There is a voluntary deadline to send the JHAQ questionnaire for the calendar year T by the 31st of March T+2. The joint health accounts questionnaire (JHAQ) is coordinated in agreement with the World Health Organisation (WHO) and the Organization of Economic Co-operation and Development (OECD). These three international organisations are known collectively as the International Health Accounts Team (IHAT). Countries submit data to Eurostat on the basis of Commission Regulation (EU) 2015/359 of 4 March 2015 implementing Regulation (EC) No 1338/2008 of the European Parliament and of the Council as regards statistics on healthcare expenditure and financing.

The 2019 JHAQ includes a number of features which allow national data correspondents to perform various quality checks before submitting the data. The embedded programmes allow the verification of:

1- Consistency of the data between tables,
This step checks if the marginal totals reported in each table of the JHAQ are consistent across all tables. For example, for each function (HC), the total across all financing schemes (HF) in the HCxHF table has to be equal to the total across all providers (HP) in the HCxHP table, i.e. the values in the column “All HF” in the HCxHF table have to be equal to the values in the column “All HP” in the HCxHP table. Any detected differences are flagged up in the corresponding row or column in the relevant tables and all inconsistencies are listed in the “Report” worksheet by variable code together with the amount by which the respective variable differs between the two compared tables. A positive value indicates that the first listed table has a higher value for the same variable, and vice versa.

2- Consistency of the data within tables,
Any detected inconsistencies are listed by variable code together with an indication of which total is not equal to the sum of its subcomponents as well as the numerical difference. A positive figure indicates that the total is greater than the reported sub-components, and vice versa.

• The presence of negative values,

Entries in the tables cannot be negative as they refer to the consumption of goods and services.
If an individual data table is checked for internal consistency, the negative values check is performed for the relevant table and then any negative values are highlighted red and crossed out.

• The presence of atypical entries,

The atypical entries check provides information whether the data tables contain values in cells which are – if at all – only reported by very few countries and are thus atypical for health accounting.
If an individual data table is checked for internal consistency, the atypical entries check is performed for the relevant table. In the data tables, any cell containing an atypical entry will be highlighted for national data providers.
Should any atypical entries be identified, compilers should scrutinize in detail the transactions that led to entries in those cells and assess whether the accounting rules of SHA have been correctly applied. If they come to the conclusion that the transactions are recorded in the correct categories of the ICHA classifications, then the corresponding atypical entries represent unique – and correctly accounted for – features of the country’s health system. In this case a short description of the nature of the transactions should be included in the accompanying Metadata file under “II.3. Atypical entries”.
If, on the other hand, compilers come to the conclusion that the transactions are not recorded correctly, then they need to make adjustments in the concerned tables. In case the transactions recorded in a cell do not belong to the boundaries of SHA (e.g. they refer to intermediate consumption) the value of the respective cell should be deleted (and all cells that are affected by this change adjusted accordingly). In case the transactions are misreported and another category of the ICHA classification is more appropriate, the value of the cell should be transferred to the correct cell of the table.

3- The growth rates against the previous year and the magnitude of revisions as compared to previously submitted data. Results are grouped into three different categories:

• Breaks in series (the current questionnaire shows no data for an item that is not null in the other file)
• Newly reported (the current questionnaire contains data for an item that is empty in the other file)
• Differences (all other types of differences)

SHA data is compiled both by a bottom-up approach as well as by a top-down approach, depending on the data source. Compilation is done by financing schemes and by different health care functions/task areas. The results of the several calculations are then aggregated.

To gain the differentiation between the different SHA-dimensions (especially HC and HP) quotas and pro-rating and utilisation keys are applied on some spending items. For some spending items it is necessary to extra-/intrapolate data as there is no up-to-date data available or data is missing for certain years. For some other spending items, estimation methods have to be applied.

Several methods are normally used for estimations:

• Balancing item/Residual method: For example, if data are available from the financing side, which permit accurate estimation of the flows to a provider or function, then an acceptable estimation method is to subtract these expenditure flows from the total revenues, and derive the expenditure flows from the unmeasured financing scheme as a residual.
• Pro-rating/Utilisation key: Typically in the absence of direct spending data, a utilisation key linked to the proportion of resources used is constructed in order to distribute e.g. aggregate provider spending across functions. For every key, a fraction of total utilisation within the cost-unit is assigned: fractions in the key add up to 100% of all care delivered by the cost-unit. Examples of utilisation keys are admissions, bed-days, contacts, staffing, etc.
• Interpolation/Extrapolation: In the absence of data for the period in question, missing values are estimated using known data points.
• Or other.

Not applicable. No data is published at national level using different methodology than SHA2011.

Authorities responsible for SHA data collection are working to ensure that the statistical practices used to compile national health accounts are in compliance with SHA methodological requirements and that good practices in the field are being followed, according to the methodology underlined in the SHA 2011 Manual and European Statistics Code of Practice respecting professional independence of the statistical authorities. Procedures are in place to plan and monitor the quality of the health care expenditure statistical production process.

The quality of statistics in CYSTAT is managed in the framework of the European Statistics Code of Practice which sets the standards for developing, producing and disseminating European Statistics as well as the ESS Quality Assurance Framework (QAF). CYSTAT endorses the Quality Declaration of the European Statistical System. In addition, CYSTAT is guided by the requirements provided for in Article 12 of the Statistics Law No. 15(I) of 2000 as well as Article 12 of Regulation (EC) No 223/2009 on European statistics, which sets out the quality criteria to be applied in the development, production and dissemination of European statistics.

European Statistics Code of Practice: https://ec.europa.eu/eurostat/documents/4031688/8971242/KS-02-18-142-EN-N.pdf/e7f85f07-91db-4312-8118-f729c75878c7

ESS Quality Assurance Framework (QAF): http://ec.europa.eu/eurostat/documents/64157/4392716/ESS-QAF-V1-2final.pdf/bbf5970c-1adf-46c8-afc3-58ce177a0646

Quality Declaration of the European Statistical System: http://ec.europa.eu/eurostat/documents/4031688/8188985/KS0217428ENN_corr.pdf/116f7c85-cd3e-4bff-b695-4a8e71385fd4

Statistics Law No. 15(I) of 2000: http://www.mof.gov.cy/mof/cystat/statistics.nsf/legislation_en/legislation_en?OpenDocument

Regulation (EC) No 223/2009 on European statistics (consolidated text): http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02009R0223-20150608&qid=1504858409240&from=EN

The overall quality of SHA data for the case of Cyprus is considered to be quite good. The main weakness is the lack of information for specific topics. These issues are outlined under points 5.3 and 6.3.1 of this report.

The main users of SHA data in Cyprus are the several ministries, i.e. Ministry of Health and the Ministry of Finance, as well as other bodies such as the National Health Insurance Organisation. Moreover, several other users are interested for SHA data, i.e. researchers, students, journalists.

CYSTAT always remains on the disposal of the SHA users for any suggestions for improvement. Any feedback from main users is considered accordingly and if it is feasible it is incorporated in the compilation of SHA.

Data is complete as far as the Commission regulation is applicable.

The only scheme for which data is not available from reference years 2016 onwards is "HF.4 Rest of the world financing schemes", due to lack of data source. However that fact does not lead to underestimation of the total health expenditure, since this expenditure is included in other HF items of the private sector.

As regards the completeness of the data according to the Regulation, it is estimated to be almost full, 100%.

Since the SHA tables are the result of integrating different data sources into a given methodology, as well as the application of several estimations in order to result in the detailed SHA categories, the outcome is inevitably not 100% accurate. 

Not applicable since no surveys are used directly for the compilation of SHA data.

Not applicable.

See point 6.3.1 below.

Βelow is the table with the variables deviating from SHA definitions or missing data. Health care goods and services by non-residents are excluded from domestic provider revenues and underground/informal/illegal health care goods and services are in large part included. Only illegally purchased medicines are partly missing.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

Not applicable.

As regards the Private Sector, since the data for the reference year are always preliminary, they are revised during the next year's submission.

Data for reference years 2010-2015 have been revised according to Eurostat's feedback during the validation procedure for the JQ2018. Specifically, the distribution of the expenditure reported under HF.1.1, HF.2.3, HF4 and HF.2.1 has been revised as described below:

- Part of the expenditure of foreign companies having branches in Cyprus (FOE) has been reclassified under HF.2.1, instead of HF.4 as was the case.

- The expenditure concerning medical funds for local government employees has been shifted from HF.1.1 that was the case, to HF.2.1.

- The expenditure concerning enterprises having their own medical funds has been shifted from HF.2.3 to HF.2.1. 

Data for reference year 2016 have been revised according to the following parameters:

- Revised figures obtained from the National Accounts division as regards the individual consumption expenditure by households (HF.3.1 and HF.3.2), has been applied in the compilation of the data.

-  Data referring to HF2.1 (Local Government Schemes, Enterprises having their own funds, as well as Bank and Union funds) that were preliminary, have been revised according to the actual data obtained from ESSPROS.

As regards the submitted data for 2017, it should be noted that the data referring to the Private Sector, as well as the depreciation for the Public Sector are preliminary.

The revisions done every year do not lead to any significant differences in the total current health expenditure. It should be noted that the latest revisions performed for reference year 2016, resulted in an increase in the total current health expenditure by 0.1%, compared to the figures before the revisions.

Member States are required to transmit their data to Eurostat in compliance with the Commission Regulation 359/2015 transmission deadlines.
Data and reference metadata for the reference year T should be transmitted to Eurostat by 30 April T+2.

The Statistical Service of Cyprus annually transmits SHA data to EUROSTAT for reference year t by 31st March t+2.

First results for year t are published in May of year t+2. 

Final results for year t are published in May of year t+3.

There were no deviations from deadlines in the reference period.

Not applicable.

Not applicable at national level.

Not applicable.

Breaks in time series resulting from methodological changes

2010-2017

Coherence is not applicable, since data from other sources, such as the National Account Data and ESSPROS data are applied to SHA2011 methodology in order to compile SHA.

Not applicable.

Consistency checks are embedded in the cross tables in advance, so CYSTAT performes these checks before submitting the data to Eurostat. No other internal consistency check are performed.

No specific news release for the dissemination of SHA data is announced. Aggregated SHA data as well as cross tables are published through the annual report “Health and Hospital Statistics”, for which an announcement is uploaded in CYSTAT’s website informing the users of the new publication.

The annual report mentioned in the previous point is usually published in April-May year t with reference year t-2, including amongst others aggregated SHA data, as well as cross tables. The publication can be downloaded for free from CYSTAT’s website, following the link below:

http://www.cystat.gov.cy/mof/cystat/statistics.nsf/populationcondition_23main_gr/populationcondition_23main_gr?OpenForm&sub=3&sel=4 and Part G regards to SHA results for year t-2. 

At national level, SHA data are not disseminated through an on-line database.

Information not available.

Not applicable.

None

The only methodological document available is the SHA 2011 manual, as well as the Metadata document submitted to Eurostat via eDamis during the data submission process.   

Not available.

Not available.

Not available. 

The data sources used for the compilation of SHA data are administrative data, as well as information obtained from other surveys that are not conducted for the needs of SHA, but their results also serve SHA purposes. Therefore, the burden on the providers and the respondents is not reflected on SHA.

Official statistics are released in accordance to all confidentiality provisions of the following:

• National Statistics Law No. 15(I) of 2000 (especially Article 13 on statistical confidentiality).

          http://www.mof.gov.cy/mof/cystat/statistics.nsf/legislation_en/legislation_en?OpenDocument 

• Regulation (EC) No 223/2009 of the European Parliament and of the Council of 11 March 2009 on European statistics and its later amendments (especially Chapter 5 on statistical confidentiality).

          http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02009R0223-20150608&qid=1504858409240&from=EN 

• European Statistics Code of Practice (especially Principle 5 on statistical confidentiality).

          https://ec.europa.eu/eurostat/documents/4031688/8971242/KS-02-18-142-EN-N.pdf/e7f85f07-91db-4312-8118-f729c75878c7 

• CYSTAT's Code of Practice for the Collection, Publication and Storage of Statistical Data.

          http://www.mof.gov.cy/mof/cystat/statistics.nsf/dmlquality_en/dmlquality_en?OpenDocument

Official statistics are released in accordance to all confidentiality provisions of the following:

National Statistics Law No. 15(I) of 2000 (especially Article 13 on statistical confidentiality).

http://www.mof.gov.cy/mof/cystat/statistics.nsf/legislation_en/legislation_en?OpenDocument

The treatment of confidential data is regulated by CYSTAT's Code of Practice for the Collection, Publication and Storage of Statistical Data.

http://www.mof.gov.cy/mof/cystat/statistics.nsf/dmlquality_en/dmlquality_en?OpenDocument

None